StockPriceToday
Alico Inc. (ALCO)
About Alico Inc.
Alico Inc. operates as an agricultural company primarily engaged in citrus farming and land stewardship activities in Florida. The company's agricultural operations make ALCO stock price sensitive to weather conditions, citrus market prices, and agricultural policy developments affecting the Florida farming industry.
The company owns and operates citrus groves producing oranges and other citrus fruits for the fresh fruit and juice markets. Alico's agricultural expertise and land management practices focus on sustainable farming methods while optimizing crop yields and quality to meet market demand for citrus products.
ALCO stock price reflects the challenges facing the Florida citrus industry, including weather-related risks, citrus diseases, and market competition from international producers. The company's land holdings also provide potential value through development opportunities and alternative agricultural uses beyond traditional citrus farming.
Alico's focus on operational efficiency and land stewardship positions the company to navigate industry challenges while exploring opportunities for diversification and value creation. The company's substantial land holdings in Florida represent valuable assets that support ALCO stock price stability and provide potential upside through strategic land management and development initiatives.
ALCO Stock 12 Month Chart
Latest News for ALCO
Alico shares currently trade at $34.44, having delivered impressive returns of 33.45% year-to-date and 8.56% in just the past week. The price target increase reflects Alico’s ongoing transition from ...
Other Popular Stocks
Nexstar Media Group Inc. (NXST) is a television broadcasting company operating local television stations and digital media platforms across the United States.
Churchill Downs Incorporated (CHDN) operates as a racing, online wagering, and gaming entertainment company, owning and operating the historic Churchill Downs racetrack and multiple...
Crinetics Pharmaceuticals Inc. (CRNX) is a clinical-stage biotechnology company focused on developing innovative treatments for rare endocrine diseases and endocrine-related tumors.